INSULIN RESISTANCE IN PATIENTS WITH CHRONIC HEART FAILURE
• 2016
Publication Information
Authors
Hamdy H. Soliman, Gamal Kenawy*, Safeya, M. Deyab"
and Osama Sanad***
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Insulin resistance may be present in patients with heart failure and has a potential to reduce
myocardial as well as skeletal muscle activity. We have assessed insulin resistance as measured by
fasting insulin resistance index (FIR!) in 23 patients with chronic heart failure (CHF) [9 valvular
disease, 6 DCM and 8 IHD] and 10 control subjects of similar age and BMI. Fasting glucose, insulin,
C-peptide and lipid profile were estimated. CHF patients had similar mean fasting plasma glucose
concentration to control but significantly higher mean plasma insulin (10.57 vs 6.14 mU//L, P< 0.001)
and C-peptide (119.4 vs 63.2, P
myocardial as well as skeletal muscle activity. We have assessed insulin resistance as measured by
fasting insulin resistance index (FIR!) in 23 patients with chronic heart failure (CHF) [9 valvular
disease, 6 DCM and 8 IHD] and 10 control subjects of similar age and BMI. Fasting glucose, insulin,
C-peptide and lipid profile were estimated. CHF patients had similar mean fasting plasma glucose
concentration to control but significantly higher mean plasma insulin (10.57 vs 6.14 mU//L, P< 0.001)
and C-peptide (119.4 vs 63.2, P
Staff Members - Benha University